Simplex Trading
LRMR icon

Simplex Trading’s Larimar Therapeutics LRMR Stock Holding History

Simplex Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,522
Closed -$122K – 9681
2025
Q4 		$116K Sell
30,522
-184,940
-86% -$719K ﹤0.01% 4844
2025
Q3 		$695K Buy
215,462
+75,038
+53% +$281K ﹤0.01% 3436
2025
Q2 		$405K Buy
140,424
+140,160
+53,091% +$324K ﹤0.01% 3736
2025
Q1 		$0 Buy
+264
New +$834 ﹤0.01% 9155
2024
Q4 		– Sell
-26,262
Closed -$173K – 9149
2024
Q3 		$172K Buy
26,262
+1,708
+7% +$13.7K ﹤0.01% 4671
2024
Q2 		$178K Sell
24,554
-36,346
-60% -$278K ﹤0.01% 4767
2024
Q1 		$462K Buy
+60,900
New +$475K ﹤0.01% 3934
2023
Q2 		– Sell
-161
Closed -$657 – 9522
2023
Q1 		$0 Buy
161
+58
+56% +$303 ﹤0.01% 9662
2022
Q4 		$0 Sell
103
-203
-66% -$693 ﹤0.01% 9876
2022
Q3 		$0 Buy
+306
New +$767 ﹤0.01% 10473
2022
Q2 		– Sell
-46
Closed -$136 – 10592
2022
Q1 		$0 Sell
46
-836
-95% -$5.47K ﹤0.01% 10978
2021
Q4 		$9K Buy
882
+725
+462% +$8.06K ﹤0.01% 9121
2021
Q3 		$1K Hold
157
– – ﹤0.01% 9652
2021
Q2 		$1K Buy
+157
New +$1.77K ﹤0.01% 9831
2019
Q3 		– Sell
-516
Closed -$7K – 7601
2019
Q2 		$7K Buy
516
+197
+62% +$5.25K ﹤0.01% 6298
2019
Q1 		$10K Sell
319
-15
-4% -$769 ﹤0.01% 6156
2018
Q4 		$19K Buy
334
+325
+3,611% +$32.1K ﹤0.01% 5372
2018
Q3 		$1K Sell
9
-21
-70% -$2.55K ﹤0.01% 7202
2018
Q2 		$3K Sell
30
-23
-43% -$1.95K ﹤0.01% 6928
2018
Q1 		$4K Buy
+53
New +$4.49K ﹤0.01% 4803
2017
Q4 		– Hold
0
– – – 6359
2017
Q3 		– Hold
0
– – – 6289
2017
Q2 		– Sell
-67
Closed -$3.43K – 6483
2017
Q1 		$3K Buy
+67
New +$3.33K ﹤0.01% 5018
2016
Q4 		– Sell
-610
Closed -$24.7K – 6228
2016
Q3 		$24K Buy
610
+507
+492% +$23K ﹤0.01% 2794
2016
Q2 		$7K Sell
103
-63
-38% -$4.98K ﹤0.01% 3938
2016
Q1 		$13K Buy
166
+74
+80% +$5.84K ﹤0.01% 3217
2015
Q4 		$6K Sell
92
-821
-90% -$132K ﹤0.01% 3744
2015
Q3 		$350K Buy
913
+504
+123% +$227K 0.03% 588
2015
Q2 		$170K Buy
+409
New +$171K 0.01% 886

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Simplex Trading's LRMR Position: Q1 2026 in Review

Simplex Trading sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 30,522 shares — an estimated $122K sold.

Simplex Trading first reported a position in LRMR in Q2 2015 and held it in 27 quarters. The position peaked at $695K in Q3 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Simplex Trading reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 30,522 Larimar Therapeutics shares in Q1 2026, an estimated $122K.
  • Simplex Trading first reported a position in Larimar Therapeutics in Q2 2015 and held it in 27 quarters.
  • Simplex Trading's Larimar Therapeutics position peaked at $695K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.